Forbes Institute for Cancer Discovery
Overview
The Forbes Institute for Cancer Discovery is a research institute within the University of Michigan's Rogel Cancer Center that provides grants to advance scientific discoveries into clinical applications for cancer prevention and treatment.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Evoq Therapeutics | - | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Forbes Institute for Cancer Discovery based?
Forbes Institute for Cancer Discovery is headquartered in Ann Arbor, Michigan, United States.
When was Forbes Institute for Cancer Discovery founded?
Forbes Institute for Cancer Discovery was founded in 2016.
How many portfolio companies does Forbes Institute for Cancer Discovery have?
Forbes Institute for Cancer Discovery has 1 portfolio company in Caplight's dataset.
What are some companies in Forbes Institute for Cancer Discovery's portfolio?
Portfolio companies visible on Caplight include Evoq Therapeutics.
What was Forbes Institute for Cancer Discovery's most recent investment shown here?
Forbes Institute for Cancer Discovery's most recent investment in this portfolio sample was in Evoq Therapeutics.
What sectors does Forbes Institute for Cancer Discovery focus on?
Forbes Institute for Cancer Discovery focuses on Healthcare & Life Sciences.
What company stages does Forbes Institute for Cancer Discovery focus on?
Stage focus information for Forbes Institute for Cancer Discovery is not publicly available.